Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Multiple Myeloma 37Neoplasms, Plasma Cell 11Recurrence 6Lymphoma, Mantle-Cell 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Peripheral Nervous System Diseases 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Immunoglobulin Light-chain Amyloidosis 2Glioblastoma 2Waldenstrom Macroglobulinemia 1Renal Insufficiency 1Rectal Neoplasms 1Pathologic Complete Response 1Paraproteinemias 1Pancreatic Neoplasms 1Ovarian Neoplasm Epithelial 1Neoplasms by Histologic Type 1Neoplasms 1Neoplasm, Residual 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Liver Neoplasms 1Leukemia, Promyelocytic, Acute 1Leukemia, Plasma Cell 1Leukemia 1Hypoxia 1

Interventions

pembrolizumab 2Hyperthermic Intraperitoneal Chemotherapy 2Gemcitabine 2Cisplatin 2niraparib 1dostarlimab 1defactinib 1Vitamin B 12 1TroVax 1Thiostrepton 1Sorafenib 1Pemetrexed 1Oxaliplatin 1Nivolumab 1Mitomycin 1MAC321 1Leucovorin 1Immunotherapy, Adoptive 1Imatinib Mesylate 1IPI-549 1Folic Acid 1Dexamethasone 1Cytoreduction Surgical Procedures 1Bortezomib 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Mesothelioma × Bortezomib × Clear all
NCT00996385 2011-10-31

Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma

Columbia University

Phase 2 Unknown
29 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡